Skip to main content
VRDN logo

Viridian Therapeutics, Inc.

VRDNNASDAQHealthcareBiotechnology

$22.37Today:- (-)1Y +3.40%

As of Oct 23, 2026 close

Market cap
$2.41B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$13.18$34.29
Volume (live)
-
Avg. volume (3M)
2.05M

Viridian Therapeutics, Inc. (VRDN) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Viridian Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 12 professional research analysts

Consensus Rating

Buy
Based on 12 unique analysts
(17 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$34.11
+52.48% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest VRDN Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Derek Archila
Wells Fargo
BuyReiterates
$31.00
Lisa Walter
RBC Capital
BuyMaintains
$38.00
Rami Katkhuda
LifeSci Capital
BuyMaintains
$35.00
Rami Katkhuda
LifeSci Capital
BuyMaintains
$35.00
Lisa Walter
RBC Capital
BuyReiterates
$36.00 → $38.00
Gregory Renza
Truist
BuyMaintains
-
Richard Law CFA
Goldman Sachs
BuyMaintains
$39.00 → $40.00
Richard Law CFA
Goldman Sachs
BuyMaintains
$39.00 → $40.00
Alex Thompson CFA
Stifel Nicolaus
BuyMaintains
$40.00
Gavin Clark-Gartner
Evercore ISI Group
BuyMaintains
$26.00
Douglas Tsao
HC Wainwright
BuyReiterates
$22.00
Joseph Thome
TD Cowen
BuyMaintains
-
Laura Chico
Wedbush
BuyMaintains
$43.00 → $41.00
Douglas Tsao
HC Wainwright
BuyReiterates
$22.00
Lachlan Hanbury Brown
William Blair
BuyMaintains
-
Joseph Thome
TD Cowen
BuyMaintains
-
Serge Belanger
Needham
BuyMaintains
$34.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 14, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for VRDN?

The analyst consensus rating for VRDN is Buy, based on the latest ratings from 12 analysts over the last 90 days.

What is the average price target for VRDN?

The average 12-month price target for VRDN is $34.11, representing an upside of 52.5% from the Oct 23, 2026 close of $22.37.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.